β-Agonists that bind to plasmalemmal β-adrenoceptors causing cAMP accumulation are widely used as bronchodilators in chronic respiratory diseases. Here, we designed and synthesized a group of 8-hydroxyquinolin-2(1H)-one analogues and studied their β-agonistic activities with a cellular cAMP assay. Compounds B05 and C08 were identified as potent (EC < 20 pM) and selective β-agonists among the compounds tested. They behaved as partial β-agonists in non-overexpressed HEK293 cells, and possessed rapid smooth muscle relaxant actions and long duration of action in isolated guinea pig tracheal strip preparations. In summary, B05 and C08 are β-agonists with potential applicability in chronic respiratory diseases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejmech.2021.113697 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!